MedPath
HSA Approval

VOYDEYA FILM-COATED TABLET 100 MG + 50 MG

SIN17152P

VOYDEYA FILM-COATED TABLET 100 MG + 50 MG

VOYDEYA FILM-COATED TABLET 100 MG + 50 MG

December 26, 2024

ASTRAZENECA SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantASTRAZENECA SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L04AJ09

Manufacturer Information

ASTRAZENECA SINGAPORE PTE LTD

Catalent CTS LLC

Hovione Farmaciencia S.A.

Active Ingredients

(100 mg tablet) Danicopan

100mg

Danicopan

(50 mg tablet) Danicopan

50mg

Danicopan

Documents

Package Inserts

Voydeya PI.pdf

Approved: December 26, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VOYDEYA FILM-COATED TABLET 100 MG + 50 MG - HSA Approval | MedPath